China Universal Asset Management Co., Ltd. Lyell Immunopharma, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 58,603 shares of LYEL stock, worth $28,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,603
Previous 59,205
1.02%
Holding current value
$28,129
Previous $37,000
16.22%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding LYEL
# of Institutions
110Shares Held
172MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$9.68 Million17.35% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$7.25 Million14.08% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$7.25 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$6.48 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$5.72 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $119M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...